Results 141 to 150 of about 48,983 (212)

OpenPVSignal Knowledge Graph: Pharmacovigilance Signal Reports in a Computationally Exploitable FAIR Representation. [PDF]

Drug Saf
Chytas A, Gavriilides G, Kapetanakis A, de Langlais A, Jaulent MC, Natsiavas P.   +5 more
europepmc   +1 more source

Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination. [PDF]

Sci Rep
Fraenza F, Cagnotta C, Gaio M, Sportiello L, Scavone C, Capuano A, Trama U.   +6 more
europepmc   +1 more source

Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System. [PDF]

Sci Rep
Chen H, Liu S, Gao S, Shi H, Yan Y, Xu Y, Fang J, Wang W, Chen H, Liu Z.   +9 more
europepmc   +1 more source

Are Causal Statements Reported in Pharmacovigilance Disproportionality Analyses Using Individual Case Safety Reports Exaggerated in Related Citations? A Meta-epidemiological Study. [PDF]

Drug Saf
Bernardeau C, Revol B, Salvo F, Fusaroli M, Raschi E, Cracowski JL, Roustit M, Khouri C.   +7 more
europepmc   +1 more source

Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase^®. [PDF]

Aging Clin Exp Res
Crescioli G, Lombardi N, Arzenton E, Luxi N, Fumagalli S, Bonaiuti R, Cacini C, Mannaioni G, Trifirò G, Moretti U, Vannacci A.   +10 more
europepmc   +1 more source

The Africa Malaria Report 2006 [PDF]

, 2006
World Health Organization , (WHO)
core  

Pharmacovigilance for Vaccines Used in Pregnancy: A Gap Analysis From Uganda. [PDF]

Pediatr Infect Dis J
Nambasa VP, Ssebagereka A, Ssali A, Namugumya R, Nalubega P, Figueras A, Kajungu D, Koch B, Le Doare K, Kampmann B.   +9 more
europepmc   +1 more source

Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System. [PDF]

Ther Adv Drug Saf
Balzano N, Mascolo A, Ruggiero D, Rafaniello C, Paolisso G, Rossi F, Capuano A.   +6 more
europepmc   +1 more source

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes. [PDF]

J Clin Psychopharmacol
de Leon J, Baldessarini RJ, Balon R, Bilbily J, Caroff SN, Citrome L, Correll CU, Cotes RO, Davis JM, DeLisi LE, Faden J, Freudenreich O, Goldsmith DR, Gurrera R, Josiassen RC, Kane JM, Kelly DL, Keshavan MS, Laitman RS, Lam YWF, Leung JG, Love RC, McCollum B, McGrane IR, Meyer JM, Nasrallah HA, Nucifora FC, Rothschild AJ, Rubio JM, Sajatovic M, Sarpal DK, Schoretsanitis G, Shad M, Shelton C, Sher L, Singh B, Surya S, Zarzar TR, Sanz EJ, De Las Cuevas C.   +39 more
europepmc   +1 more source